Results 221 to 230 of about 265,775 (287)

Blocking dopamine receptor 2 decreases gastrin levels in H. pylori-infected mice through increasing gastric somatostatin content

open access: bronze
Qun Shen   +11 more
openalex   +1 more source

Polydopamine‐Mediated Silver and Nickel Metallization of Phase Change Microcapsules for Multifunctional Flexible Epoxy Composites

open access: yesJournal of Applied Polymer Science, EarlyView.
An eco‐friendly, polydopamine‐assisted electroless metallization of phase change microcapsules enables thin silver or nickel coatings that preserve phase‐change functionality and while enhancing thermal diffusivity and thermomechanical performance in flexible epoxy composites.
Giulia Fredi   +3 more
wiley   +1 more source

Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase

open access: green, 2012
Yu Yang   +10 more
openalex   +2 more sources

D4 Dopamine and Metabotropic Glutamate Receptors in Cerebral Cortex and Striatum in Rat Brain [PDF]

open access: bronze, 2001
María Alejandra Berger   +3 more
openalex   +1 more source

Hierarchical MXene–Carbon Nanotube Architectures for High‐Stability Silicon Oxide Anodes

open access: yesBatteries &Supercaps, EarlyView.
A novel MXene–CNT hierarchical framework is synthesized via molecularly driven assembly and crosslinking, enabling electrically interconnected and mechanically reinforced Si/SiOx/C composite anodes. The CNTs bridge the MXene flakes to form a robust conductive network, while the MXene surface chemistry facilitates uniform SiOx/C coating and SEI ...
Xiang Guan   +3 more
wiley   +1 more source

D1-like dopamine receptors promote B-cell differentiation in systemic lupus erythematosus. [PDF]

open access: yesCell Commun Signal
Xiang Z   +8 more
europepmc   +1 more source

Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse. [PDF]

open access: yesAddict Biol, 2022
Say FM   +7 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Home - About - Disclaimer - Privacy